Oral prolonged-release ketamine in treatment-resistant depression - A double-blind randomized placebo-controlled multicentre trial of KET01, a novel ketamine formulation – Clinical and safety results
Michael Colla, Benjamin Offenhammer, Hanne Scheerer, Golo Kronenberg, Stefan Vetter, Jochen Mutschler, Thorsten Mikoteit, Anna Bankwitz, Atalìa Adank, Linda Schaekel, Corinne Eicher, Annette Beatrix Brühl, Erich Seifritz
Topics & Concepts
PlaceboMedicineAdverse effectRandomized controlled trialAnesthesiaInternal medicineKetamineAlternative medicinePathologyTreatment of Major DepressionTryptophan and brain disordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes